Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Total Non-Current Liabilities (2016 - 2021)

OptimizeRx's Total Non-Current Liabilities history spans 12 years, with the latest figure at $260614.0 for Q3 2021.

  • For Q3 2021, Total Non-Current Liabilities fell 26.92% year-over-year to $260614.0; the TTM value through Sep 2021 reached $260614.0, down 26.92%, while the annual FY2020 figure was $325533.0, 94.26% down from the prior year.
  • Total Non-Current Liabilities for Q3 2021 was $260614.0 at OptimizeRx, down from $282934.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $5.7 million in Q4 2019 and bottomed at $260614.0 in Q3 2021.
  • The 5-year median for Total Non-Current Liabilities is $1.6 million (2017), against an average of $1.6 million.
  • The largest annual shift saw Total Non-Current Liabilities surged 512.12% in 2017 before it crashed 94.26% in 2020.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $2.3 million in 2017, then rose by 4.8% to $2.4 million in 2018, then surged by 139.69% to $5.7 million in 2019, then plummeted by 94.26% to $325533.0 in 2020, then dropped by 19.94% to $260614.0 in 2021.
  • Per Business Quant, the three most recent readings for OPRX's Total Non-Current Liabilities are $260614.0 (Q3 2021), $282934.0 (Q2 2021), and $305039.0 (Q1 2021).